Cardlytics
American company
CDLX Nasdaq
ISIN US14161W1053 SEC CIK 1666071 LEI 549300JETJBH94EIPC66
Follow Cardlytics
Weekly email: filings, results
Revenue, last quarter
$32.9M
−30% vs same quarter last year
Net income
−$8.9M
+87.7% vs same quarter last year
EPS, diluted
-
Operating cash flow
−$5.9M
−435% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $212.3M | −$104M |
| FY24 | $255.6M | −$189M |
| FY23 | $285.4M | −$135M |
| FY22 | $277.2M | −$465.3M |
| FY21 | $258.8M | −$128.6M |
| FY20 | $186.9M | −$55.4M |
| FY19 | $210.4M | −$17.1M |
| FY18 | $150.7M | −$53M |
| FY17 | $130.4M | −$19.6M |
| FY16 | $112.8M | −$75.7M |
| FY15 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −48% | −49% |
| FY24 | −76.5% | −73.9% |
| FY23 | −47.5% | −47.3% |
| FY22 | −165.2% | −167.9% |
| FY21 | −47.4% | −49.7% |
| FY20 | −28.9% | −29.7% |
| FY19 | −8.2% | −8.1% |
| FY18 | −27.2% | −35.2% |
| FY17 | −13.1% | −15.1% |
| FY16 | −49.8% | −67.1% |
| FY15 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $8.8M |
| FY24 | −$10.4M |
| FY23 | −$852K |
| FY22 | −$55.1M |
| FY21 | −$41.6M |
| FY20 | −$13M |
| FY19 | $3.2M |
| FY18 | −$24.9M |
| FY17 | −$23.3M |
| FY16 | −$34.3M |
| FY15 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | - |
| FY24 | $0 |
| FY23 | $0 |
| FY22 | $40M |
| FY21 | $0 |
| FY20 | $0 |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
- Cardlytics
- Technology median
Show the numbers
| Year | Cardlytics | Technology median |
|---|---|---|
| FY25 | −49% | −2.4% |
| FY24 | −73.9% | −5% |
| FY23 | −47.3% | −6.7% |
| FY22 | −167.9% | −4.4% |
| FY21 | −49.7% | −1.7% |
| FY20 | −29.7% | −3% |
| FY19 | −8.1% | 0% |
| FY18 | −35.2% | 0.8% |
| FY17 | −15.1% | 2% |
| FY16 | −67.1% | 2.3% |
| FY15 | - | 3.1% |